PURE Bioscience, Inc. Proceeds from Related Party Debt
PURE Bioscience, Inc. (PURE) reported Proceeds from Related Party Debt of $970.00 thousand for the 9-month period ending 2026-04-30, per its 10-Q filed 2026-06-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRelatedPartyDebt · last filed 2026-06-15
- PURE Bioscience, Inc. proceeds from related party debt for the quarter ending 2026-04-30 was $250.00K, a 70.59% decline year-over-year.
- PURE Bioscience, Inc. proceeds from related party debt for the quarter ending 2026-01-31 was $370.00K, a 7.50% decline year-over-year.
- PURE Bioscience, Inc. proceeds from related party debt for the quarter ending 2025-10-31 was $350.00K, a 30.00% decline year-over-year.
- PURE Bioscience, Inc. proceeds from related party debt for the quarter ending 2025-07-31 was $250.00K, a 50.00% decline year-over-year.
- PURE Bioscience, Inc. proceeds from related party debt for fiscal 2025 was $2.00M, a 12.04% increase from fiscal 2024.
- PURE Bioscience, Inc. proceeds from related party debt for fiscal 2024 was $1.78M, a 75.86% increase from fiscal 2023.
- PURE Bioscience, Inc. proceeds from related party debt for fiscal 2023 was $1.01M.
| Period end | Proceeds from Related Party Debt 3 month | Proceeds from Related Party Debt 6 month | Proceeds from Related Party Debt 9 month | Proceeds from Related Party Debt 12 month |
|---|---|---|---|---|
| 2026-04-30 | $250.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-15 | $620.00K derived: sum of 2 quarters · filed 2026-06-15 | $970.00K 10-Q · filed 2026-06-15 | $1.22M derived: sum of 4 quarters · filed 2026-06-15 |
| 2026-01-31 | $370.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-17 | $720.00K 10-Q · filed 2026-03-17 | $970.00K derived: sum of 3 quarters · filed 2026-03-17 | $1.82M derived: sum of 4 quarters · filed 2026-06-15 |
| 2025-10-31 | $350.00K 10-Q · filed 2025-12-15 | $600.00K derived: sum of 2 quarters · filed 2025-12-15 | $1.45M derived: sum of 3 quarters · filed 2026-06-15 | $1.85M derived: sum of 4 quarters · filed 2026-06-15 |
| 2025-07-31 | $250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $1.10M derived: sum of 2 quarters · filed 2026-06-15 | $1.50M derived: sum of 3 quarters · filed 2026-06-15 | $2.00M 10-K · filed 2025-10-29 |
| 2025-04-30 | $850.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-15 | $1.25M derived: sum of 2 quarters · filed 2026-06-15 | $1.75M 10-Q · filed 2026-06-15 | $2.25M derived: sum of 4 quarters · filed 2026-06-15 |
| 2025-01-31 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-17 | $900.00K 10-Q · filed 2026-03-17 | $1.40M derived: sum of 3 quarters · filed 2026-03-17 | $1.90M derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-10-31 | $500.00K 10-Q · filed 2025-12-15 | $1.00M derived: sum of 2 quarters · filed 2025-12-15 | $1.50M derived: sum of 3 quarters · filed 2025-12-15 | $1.50M derived: sum of 4 quarters · filed 2025-12-15 |
| 2024-07-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $1.00M derived: sum of 2 quarters · filed 2025-10-29 | $1.00M derived: sum of 3 quarters · filed 2025-10-29 | $1.78M 10-K · filed 2025-10-29 |
| 2024-04-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-06-16 | $500.00K derived: sum of 2 quarters · filed 2025-06-16 | $1.28M 10-Q · filed 2025-06-16 | |
| 2024-01-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-03-17 | $785.00K 10-Q · filed 2025-03-17 | ||
| 2023-10-31 | $785.00K 10-Q · filed 2024-12-16 | |||
| 2023-07-31 | $1.01M 10-K · filed 2023-10-30 |